(Neo:VRNO.NE),(OTC US:VRNOF),(OtherOTC:VRNOF), Raw Garden Live Resin Terpene Cartridges and All-in-One Vapes will be sold at Verano's Four New Jersey Zen Leaf dispensaries and third-party retailers beginning November 11th. CHICAGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced an […]

(TSX-V:IVS), TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce that processing of the 007 North bulk sample from its wholly-owned Pardo Gold Project, located 65 km northeast of Sudbury, Ontario, is ongoing at McEwen Inc.'s Stock Mill. Highlights Milling is currently underway for

BASEL, Switzerland and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — Noema Pharma AG today announced positive topline results from a Phase 2a, open-label study evaluating cendifensine in menopausal women experiencing moderate-to-severe vasomotor symptoms (VMS), including hot flashes and night sweats. The results suggest that cendifensine may be an effective and well-tolerated, non-hormonal therapeutic option for

(NASDAQ:GLUE), Second agreement signed with Novartis to develop novel degraders for immune-mediated diseases, providing upfront payment of $120 million plus option maintenance payments, and eligibility for option exercise payments, milestones, and tiered royalties Phase 1 study of NEK7-directed MGD MRT-8102 underway, investigating a potential novel approach to treat inflammatory diseases driven by the NLRP3 inflammasome;

(NASDAQ:TENX), CHAPEL HILL, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will host a conference call and webcast on Thursday, November 13, 2025, at 4:30 p.m. ET.

(NASDAQ:ACHV), One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner's National Priority Voucher for E-cigarette or Vaping Cessation Conference Call Scheduled for 8:30 AM EST Today, November 6, 2025 SEATTLE and VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on

(NasdaqGM:ALT), 48-week Data from Phase 2b IMPACT Trial of Pemvidutide in MASH Expected Before Year End End-of-Phase 2 Meeting with FDA for MASH Program Scheduled in Fourth Quarter Executive Leadership Strengthened with Appointments of Chief Medical Officer, Chief Commercial Officer, and Chief Legal Officer Cash, cash equivalents and short-term investments of $211 million as of

(NASDAQ:GOGO), Total Revenue of $223.6 million, up 122% Year-over-Year; Service Revenue of $190.0 million, up 132% Year-over-Year Net Loss of $1.9 million, which includes a $15 million pre-tax acquisition-related earn-out accrual Adjusted EBITDA(1) of $56.2 million, up 61% Year-over-Year Over 200 Year to Date shipments of Gogo's new cutting-edge Low Earth Orbit HDX antenna On

(NASDAQ:LNSR), 18 ALLY Robotic Cataract Laser Systems(R) (“ALLY Systems”) placed in 3Q 2025; Backlog of 18 ALLY Systems pending installation as of September 30, 2025 ALLY installed base grew 77% and total laser installed base grew 20% over 3Q 2024 ORLANDO, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the

(NASDAQ:MTRX), TULSA, Okla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX), a leading contractor to the energy and industrial markets across North America, today announced that Delaware River Partners has awarded Matrix NAC the construction for balance of plant work supporting a 100,000 m3, (630,000 barrels), dual service full containment storage tank